+

WO1993017651A3 - Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung - Google Patents

Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung Download PDF

Info

Publication number
WO1993017651A3
WO1993017651A3 PCT/DE1993/000213 DE9300213W WO9317651A3 WO 1993017651 A3 WO1993017651 A3 WO 1993017651A3 DE 9300213 W DE9300213 W DE 9300213W WO 9317651 A3 WO9317651 A3 WO 9317651A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
nucleoside analogues
antiviral nucleoside
antiviral
disclosed
Prior art date
Application number
PCT/DE1993/000213
Other languages
English (en)
French (fr)
Other versions
WO1993017651A2 (de
Inventor
Eckart Matthes
Janta-Lipinski Martin Von
Original Assignee
Max Delbrueck Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum filed Critical Max Delbrueck Centrum
Publication of WO1993017651A2 publication Critical patent/WO1993017651A2/de
Publication of WO1993017651A3 publication Critical patent/WO1993017651A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die Erfindung betrifft neue und bekannte Nucleosidanaloga, die insbesondere gegen Hepatitis B- und gegen HIV-Infektionen wirksam sind, ihre Herstellung und ihre Verwendung.
PCT/DE1993/000213 1992-03-04 1993-03-03 Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung WO1993017651A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4207363.4 1992-03-04
DE19924207363 DE4207363A1 (de) 1992-03-04 1992-03-04 Antivirale nucleosidanaloga, ihre herstellung und ihre pharmazeutische verwendung

Publications (2)

Publication Number Publication Date
WO1993017651A2 WO1993017651A2 (de) 1993-09-16
WO1993017651A3 true WO1993017651A3 (de) 1993-11-25

Family

ID=6453548

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1993/000213 WO1993017651A2 (de) 1992-03-04 1993-03-03 Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung

Country Status (2)

Country Link
DE (1) DE4207363A1 (de)
WO (1) WO1993017651A2 (de)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9109001B2 (en) 2012-05-22 2015-08-18 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphoramidate prodrugs for HCV infection
US9187515B2 (en) 2013-04-01 2015-11-17 Idenix Pharmaceuticals Llc 2′,4′-fluoro nucleosides for the treatment of HCV
US9192621B2 (en) 2012-09-27 2015-11-24 Idenix Pharmaceuticals Llc Esters and malonates of SATE prodrugs
US9211300B2 (en) 2012-12-19 2015-12-15 Idenix Pharmaceuticals Llc 4′-fluoro nucleosides for the treatment of HCV
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
US9296778B2 (en) 2012-05-22 2016-03-29 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphate prodrugs for HCV infection
US9309275B2 (en) 2013-03-04 2016-04-12 Idenix Pharmaceuticals Llc 3′-deoxy nucleosides for the treatment of HCV
US9403863B2 (en) 2011-09-12 2016-08-02 Idenix Pharmaceuticals Llc Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
US10005779B2 (en) 2013-06-05 2018-06-26 Idenix Pharmaceuticals Llc 1′,4′-thio nucleosides for the treatment of HCV
US10202411B2 (en) 2014-04-16 2019-02-12 Idenix Pharmaceuticals Llc 3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV
US10231986B2 (en) 2013-03-13 2019-03-19 Idenix Pharmaceuticals Llc Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCV
US10238680B2 (en) 2013-08-01 2019-03-26 Idenix Pharmaceuticals Llc D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022330A1 (en) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
PL359169A1 (en) 2000-05-26 2004-08-23 Idenix (Cayman) Limited Methods and compositions for treating flaviviruses and pestiviruses
GB0114286D0 (en) 2001-06-12 2001-08-01 Hoffmann La Roche Nucleoside Derivatives
BR0316363A (pt) 2002-11-15 2005-10-04 Idenix Cayman Ltd Nucleosìdeos 2'-ramificado e mutação de flaviviridae
TWI332507B (en) * 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
CN100351264C (zh) * 2002-11-19 2007-11-28 霍夫曼-拉罗奇有限公司 抗病毒核苷衍生物
EP1937825B1 (de) * 2005-09-26 2016-12-21 Gilead Pharmasset LLC Modifizierte 4'-nukleoside als antivirusmittel
US20080261913A1 (en) 2006-12-28 2008-10-23 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of liver disorders
DK2737085T3 (en) * 2011-07-29 2017-01-23 Cambridge Epigenetix Ltd METHODS FOR DETECTING NUCLEOTID MODIFICATION
SG11201407674TA (en) 2012-05-22 2014-12-30 Idenix Pharmaceuticals Inc D-amino acid compounds for liver disease
EP2861611B1 (de) 2012-05-25 2016-07-13 Janssen Sciences Ireland UC Uracyl-spirooxetan-nukleoside
SG11201502750UA (en) 2012-10-08 2015-06-29 Idenix Pharmaceuticals Inc 2'-chloro nucleoside analogs for hcv infection
WO2014137930A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. Thiophosphate nucleosides for the treatment of hcv
CN104193801A (zh) * 2014-08-12 2014-12-10 苏州维泰生物技术有限公司 一种鸟嘌呤肽核酸单体及其合成方法
WO2019173602A1 (en) * 2018-03-07 2019-09-12 Emory University 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0277599A2 (de) * 1987-01-30 1988-08-10 Asahi Glass Company Ltd. Fluor enthaltende Cyclopentandenivate und Verfahren zu ihrer Herstellung
EP0322384A1 (de) * 1987-11-03 1989-06-28 Medivir Aktiebolag Nucleoside zur Verwendung für die Therapie
EP0375183A1 (de) * 1988-12-05 1990-06-27 Schering Corporation Antivirale Dimere und Trimere
WO1991019727A1 (en) * 1990-06-19 1991-12-26 Sloan-Kettering Institute For Cancer Research 5'-hydrogenphosphonates and 5'-methylphosphonates of sugar modified nucleosides, compositions and uses thereof
EP0464642A1 (de) * 1990-07-02 1992-01-08 Hoechst Aktiengesellschaft Pyrimidin-Derivate, deren Herstellung und Verwendung sowie diese enthaltende Arzneimittel
EP0302760B1 (de) * 1987-08-07 1992-07-29 The Governors of the University of Alberta Antivirale Therapie gegen Hepatitis B mit 2',3'-Didesoxynucleosiden

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0277599A2 (de) * 1987-01-30 1988-08-10 Asahi Glass Company Ltd. Fluor enthaltende Cyclopentandenivate und Verfahren zu ihrer Herstellung
EP0302760B1 (de) * 1987-08-07 1992-07-29 The Governors of the University of Alberta Antivirale Therapie gegen Hepatitis B mit 2',3'-Didesoxynucleosiden
EP0322384A1 (de) * 1987-11-03 1989-06-28 Medivir Aktiebolag Nucleoside zur Verwendung für die Therapie
EP0375183A1 (de) * 1988-12-05 1990-06-27 Schering Corporation Antivirale Dimere und Trimere
WO1991019727A1 (en) * 1990-06-19 1991-12-26 Sloan-Kettering Institute For Cancer Research 5'-hydrogenphosphonates and 5'-methylphosphonates of sugar modified nucleosides, compositions and uses thereof
EP0464642A1 (de) * 1990-07-02 1992-01-08 Hoechst Aktiengesellschaft Pyrimidin-Derivate, deren Herstellung und Verwendung sowie diese enthaltende Arzneimittel

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF ORGANIC CHEMISTRY. Bd. 41, Nr. 18, 3. September 1976, EASTON US Seiten 3010 - 3017 G.R.OWEN ET AL. '4'-Substituted Nucleosides. 3.Synthesis of Some 4'-Fluorouridine Derivatives.' *
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. Bd. 98, Nr. 11, 26. Mai 1976, GASTON, PA US Seiten 3346 - 3357 I.D.JENKINS ET AL. '4'-Substituted Nucleosides. 2. Synthesis of the Nucleoside Antibiotic Nucleocidin.' *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
US9403863B2 (en) 2011-09-12 2016-08-02 Idenix Pharmaceuticals Llc Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
US9109001B2 (en) 2012-05-22 2015-08-18 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphoramidate prodrugs for HCV infection
US9296778B2 (en) 2012-05-22 2016-03-29 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphate prodrugs for HCV infection
US9192621B2 (en) 2012-09-27 2015-11-24 Idenix Pharmaceuticals Llc Esters and malonates of SATE prodrugs
US9211300B2 (en) 2012-12-19 2015-12-15 Idenix Pharmaceuticals Llc 4′-fluoro nucleosides for the treatment of HCV
US9309275B2 (en) 2013-03-04 2016-04-12 Idenix Pharmaceuticals Llc 3′-deoxy nucleosides for the treatment of HCV
US10231986B2 (en) 2013-03-13 2019-03-19 Idenix Pharmaceuticals Llc Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCV
US9187515B2 (en) 2013-04-01 2015-11-17 Idenix Pharmaceuticals Llc 2′,4′-fluoro nucleosides for the treatment of HCV
US10005779B2 (en) 2013-06-05 2018-06-26 Idenix Pharmaceuticals Llc 1′,4′-thio nucleosides for the treatment of HCV
US10238680B2 (en) 2013-08-01 2019-03-26 Idenix Pharmaceuticals Llc D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
US10202411B2 (en) 2014-04-16 2019-02-12 Idenix Pharmaceuticals Llc 3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV

Also Published As

Publication number Publication date
DE4207363A1 (de) 1993-09-09
WO1993017651A2 (de) 1993-09-16

Similar Documents

Publication Publication Date Title
WO1993017651A3 (de) Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung
CA2068943A1 (en) 1,3-oxathiolanes useful in the treatment of hepatitis
NL960025I1 (nl) Gesubstitueerde 1,3-oxathiolanen met antivirale activiteit.
AU6924796A (en) 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c
FI906212A0 (fi) Inhibitorer foer hiv-proteas, vilka aer anvaendbara vid av aids.
IT9000642A0 (it) Metil pirrolidon chitosano, processo di produzione e suoi usi.
ZA913293B (en) 1,3-oxathiolane nucleoside analogues
AU1437292A (en) Antiviral 1,3-dioxolane nucleosides and synthesis thereof
AU2001248331A1 (en) Medicaments against viral diseases
AP9200414A0 (en) 1,3-oxathiolane nucleoside analogues
EP1164133A3 (de) Enantiomerisch reine Beta-D-Dioxolan-Nukleoside
AU7855191A (en) 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents
CA2143204A1 (en) Use of Dideoxy Nucleoside Analogues in the Treatment of Viral Infections
AU626726B2 (en) Uracil derivatives, and their production and use
DE69000743D1 (de) Antivirale tetrahydroimidazo(1,4)benzodiazepin-2-thione.
FI935780A0 (fi) HIV-proteasinhibitorer, vilka aer anvaendbara vid behandling av AIDS
CA2120743A1 (en) Antiviral acyclic phosphonomethoxyalkyl substituted, alkenyl and alkynyl purine and pyrimidine derivatives
HUP0100087A3 (en) Nucleosides analogues, the use thereof for producing medicaments useful against retroviral infections and hepatitis b virus and the same medicaments
DE68918215D1 (de) 2'-Halomethyliden, 2'-Ethenyliden und 2'-Ethynyl-Adenosinderivate.
EP0317128A3 (de) Anti-HIV Pyrimidin Nucleoside
AU3170193A (en) Therapeutic nucleosides
AU8177791A (en) New embodiments of the hiv principal neutralizing determinant
FI890116L (fi) Icke-reverterande rna-virus.
AU9179891A (en) Hiv reverse transcriptase vaccine
CA2285463A1 (en) A combination therapy for hiv infections

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载